Dr. Rubina Qamar
Claim this profileAurora Saint Luke's Medical Center
Expert in Breast Cancer
Expert in Cancer
26 reported clinical trials
72 drugs studied
About Rubina Qamar
Education:
- Earned MD from Dow University of Health Sciences.
- Completed Internship at Civil Hospital/Dow Medical College.
- Residency in Internal Medicine at Loyola University Medical Center.
- Fellowship in Hematology/Oncology at Loyola University Medical Center (ACGME accredited).
Experience:
- Board certified in Hematology and Medical Oncology by the American Board of Internal Medicine.
- Affiliated with Aurora St. Luke's Medical Center, Aurora St. Luke's South Shore, and Aurora Sinai Medical Center.
Area of expertise
1Breast Cancer
Global LeaderHER2 positive
ER negative
ER positive
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Affiliated Hospitals
Aurora Saint Luke's Medical Center
Aurora Cancer Care-Grafton
Clinical Trials Rubina Qamar is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Rubina Qamar
Clinical Trial Related1 year of experience running clinical trials · Led 26 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Rubina Qamar has experience with
- Paclitaxel
- Atezolizumab
- Docetaxel
- Pembrolizumab
- Carboplatin
- Gemcitabine Hydrochloride
Breakdown of trials Rubina Qamar has run
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rubina Qamar specialize in?
Rubina Qamar focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER negative.
Is Rubina Qamar currently recruiting for clinical trials?
Yes, Rubina Qamar is currently recruiting for 9 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Rubina Qamar has studied deeply?
Yes, Rubina Qamar has studied treatments such as Paclitaxel, Atezolizumab, Docetaxel.
What is the best way to schedule an appointment with Rubina Qamar?
Apply for one of the trials that Rubina Qamar is conducting.
What is the office address of Rubina Qamar?
The office of Rubina Qamar is located at: Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin 53215 United States. This is the address for their practice at the Aurora Saint Luke's Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.